Skip to main content
. 2013 Apr 3;8(4):e60516. doi: 10.1371/journal.pone.0060516

Figure 4. Receive operating characteristic curve analysis for several clinicopathological features and Beclin 1 expression was used to evaluate the survival status.

Figure 4

(A) Age [area under curve (AUC) = 0.487, P = 0.769], histological grade (AUC = 0.588, P = 0.054), FIGO stage (AUC = 0.750, P<0.0001), pT status (AUC = 0.638, P = 0.003), pN status (AUC = 0.599, P = 0.031), pM status (AUC = 0.614, P = 0.012), histological type (AUC = 0.446, P = 0.242),Beclin 1 expression (AUC = 0.673, P<0.0001) and Bcl-xL (AUC = 0.588, P = 0.056) implied statistical associations with the survival in whole study population. (B) Age (AUC = 0.504, P = 0.943), histological grade (AUC = 0.609, P = 0.044), FIGO stage (AUC = 0.767, P<0.0001), pT status (AUC = 0.617, P = 0.030), pN status (AUC = 0.625, P = 0.020), pM status (AUC = 0.631, P = 0.015), histological type (AUC = 0.472, P = 0.598),and Beclin 1 expression (AUC = 0.675, P<0.0001) were applied to test the survival status in highly-expressed Bcl-xL population. (C) Age (AUC = 0.449, P = 0.583), histological grade (AUC = 0.511, P = 0.907), FIGO stage (AUC = 0.714, P = 0.022), pT status (AUC = 0.744, P = 0.009), pN status (AUC = 0.551, P = 0.583), pM status (AUC = 0.551, P = 0.583), histological type (AUC = 0.427, P = 0.434),and Beclin 1 expression (AUC = 0.603, P = 0.272) were employed to evaluate the survival in low-expressed Bcl-xL population.